153 related articles for article (PubMed ID: 23813239)
41. Biomimetic CaP coating incorporated with parathyroid hormone improves the osseointegration of titanium implant.
Yu X; Wang L; Jiang X; Rowe D; Wei M
J Mater Sci Mater Med; 2012 Sep; 23(9):2177-86. PubMed ID: 22639151
[TBL] [Abstract][Full Text] [Related]
42. The effects of therapeutic doses of irradiation on experimental bone graft incorporation over a porous-coated segmental defect endoprosthesis.
Chin HC; Frassica FJ; Markel MD; Frassica DA; Sim FH; Chao EY
Clin Orthop Relat Res; 1993 Apr; (289):254-66. PubMed ID: 8472425
[TBL] [Abstract][Full Text] [Related]
43. Effect of alendronate on endosseous implant integration: an in vivo study in rabbits.
Chacon GE; Stine EA; Larsen PE; Beck FM; McGlumphy EA
J Oral Maxillofac Surg; 2006 Jul; 64(7):1005-9. PubMed ID: 16781331
[TBL] [Abstract][Full Text] [Related]
44. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: histologic observations.
Polimeni G; Wikesjö UM; Susin C; Qahash M; Shanaman RH; Prasad HS; Rohrer MD; Hall J
J Clin Periodontol; 2010 Aug; 37(8):759-68. PubMed ID: 20500538
[TBL] [Abstract][Full Text] [Related]
45. Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur.
Tao ZS; Zhou WS; Qiang Z; Tu KK; Huang ZL; Xu HM; Sun T; Lv YX; Cui W; Yang L
J Biomater Appl; 2016 Feb; 30(7):952-60. PubMed ID: 26482573
[TBL] [Abstract][Full Text] [Related]
46. The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model.
Eberhardt C; Habermann B; Müller S; Schwarz M; Bauss F; Kurth AH
J Orthop Sci; 2007 Jan; 12(1):61-6. PubMed ID: 17260119
[TBL] [Abstract][Full Text] [Related]
47. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
[TBL] [Abstract][Full Text] [Related]
48. Strontium in the bone-implant interface.
Vestermark MT
Dan Med Bull; 2011 May; 58(5):B4286. PubMed ID: 21535993
[TBL] [Abstract][Full Text] [Related]
49. Effect of topical alendronate treatment on fixation of implants inserted with bone compaction.
Jakobsen T; Kold S; Bechtold JE; Elmengaard B; Søballe K
Clin Orthop Relat Res; 2006 Mar; 444():229-34. PubMed ID: 16523143
[TBL] [Abstract][Full Text] [Related]
50. Ultraviolet-C irradiation to titanium implants increases peri-implant bone formation without impeding mineralization in a rabbit femur model.
Yamazaki M; Yamada M; Ishizaki K; Sakurai K
Acta Odontol Scand; 2015 May; 73(4):302-11. PubMed ID: 25645878
[TBL] [Abstract][Full Text] [Related]
51. Analysis of periprosthetic tissue formation around a porous titanium endoprosthesis using CT-based spatial reconstruction.
Young DR; Robb RA; Rock MG; Chao EY
J Comput Assist Tomogr; 1994; 18(3):461-8. PubMed ID: 8188917
[TBL] [Abstract][Full Text] [Related]
52. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.
Chen B; Li Y; Yang X; Xu H; Xie D
Osteoporos Int; 2013 Jul; 24(7):2115-21. PubMed ID: 23389695
[TBL] [Abstract][Full Text] [Related]
53. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. An experimental pilot study in dogs.
Schliephake H; Scharnweber D; Dard M; Rössler S; Sewing A; Meyer J; Hoogestraat D
Clin Oral Implants Res; 2002 Jun; 13(3):312-9. PubMed ID: 12010163
[TBL] [Abstract][Full Text] [Related]
54. Osseointegration of cementless implants with different bisphosphonate regimens.
Eberhardt C; Stumpf U; Brankamp J; Schwarz M; Kurth AH
Clin Orthop Relat Res; 2006 Jun; 447():195-200. PubMed ID: 16467623
[TBL] [Abstract][Full Text] [Related]
55. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): histological observations.
Susin C; Qahash M; Polimeni G; Lu PH; Prasad HS; Rohrer MD; Hall J; Wikesjö UM
J Clin Periodontol; 2010 Jun; 37(6):574-81. PubMed ID: 20345394
[TBL] [Abstract][Full Text] [Related]
56. The synergistic effect of hierarchical micro/nano-topography and bioactive ions for enhanced osseointegration.
Zhang W; Wang G; Liu Y; Zhao X; Zou D; Zhu C; Jin Y; Huang Q; Sun J; Liu X; Jiang X; Zreiqat H
Biomaterials; 2013 Apr; 34(13):3184-95. PubMed ID: 23380352
[TBL] [Abstract][Full Text] [Related]
57. Effect of local zoledronate on implant osseointegration in a rat model.
Back DA; Pauly S; Rommel L; Haas NP; Schmidmaier G; Wildemann B; Greiner SH
BMC Musculoskelet Disord; 2012 Mar; 13():42. PubMed ID: 22439827
[TBL] [Abstract][Full Text] [Related]
58. Fixation of a double-coated titanium-hydroxyapatite focal knee resurfacing implant: a 12-month study in sheep.
Martinez-Carranza N; Berg HE; Lagerstedt AS; Nurmi-Sandh H; Schupbach P; Ryd L
Osteoarthritis Cartilage; 2014 Jun; 22(6):836-44. PubMed ID: 24726379
[TBL] [Abstract][Full Text] [Related]
59. The effect of magnesium-incorporated hydroxyapatite coating on titanium implant fixation in ovariectomized rats.
Li X; Li Y; Liao Y; Li J; Zhang L; Hu J
Int J Oral Maxillofac Implants; 2014; 29(1):196-202. PubMed ID: 24451871
[TBL] [Abstract][Full Text] [Related]
60. A technique for evaluating bone ingrowth into 3D printed, porous Ti6Al4V implants accurately using X-ray micro-computed tomography and histomorphometry.
Palmquist A; Shah FA; Emanuelsson L; Omar O; Suska F
Micron; 2017 Mar; 94():1-8. PubMed ID: 27960108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
